Is the true clinical value of high-sensitivity troponins as a biomarker of risk? The concept that detection of high-sensitivity troponin ‘never means nothing’

References

• Ruigómez A, Rodríguez LA, Wallander MA, et al. Chest pain in general practice: incidence, comorbidity and mortality. Fam Pract. 2006;23(2):167–174.
   PubMed Web of Science ®Google Scholar
• Goodacre S, Cross E, Arnold J, et al. The health care burden of acute chest pain. Heart. 2005;91(2):229–230.
   PubMed Web of Science ®Google Scholar
• Global Health Observatory (GHO) dataTop 10 causes of death: World Health Organisation; 2018 [cited 2020 Jun 10]. Available from http://origin.who.int/gho/mortality_burden_disease/causes_death/top_10/en/.
   Google Scholar
• Takeda S, Yamashita A, Maeda K, et al. Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form. Nature. 2003;424(6944):35–41.
   PubMed Web of Science ®Google Scholar
• Dolci A, Panteghini M. The exciting story of cardiac biomarkers: from retrospective detection to gold diagnostic standard for acute myocardial infarction and more. Clin Chim Acta. 2006;369(2):179–187.
   PubMed Web of Science ®Google Scholar
• Reichlin T, Hochholzer W, Bassetti S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009;361(9):858–867.
   PubMed Web of Science ®Google Scholar
• Smulders MW, Kietselaer BL, Schalla S, et al. Acute chest pain in the high-sensitivity cardiac troponin era: A changing role for noninvasive imaging? Am Heart J. 2016;177:102–111.
   PubMed Web of Science ®Google Scholar
• Keller T, Zeller T, Ojeda F, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA. 2011;306(24):2684–2693.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Mair J, Katus H, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J. 2010;31(18):2197–2204.
   PubMed Web of Science ®Google Scholar
• Mariathas M, Curzen N. Troponin assays: developing indications. Lancet. 2018;391(10138):2398–2399.
   PubMed Web of Science ®Google Scholar
• Collinson P, Lindahl B. Type 2 myocardial infarction: the chimaera of cardiology? Heart. 2015;101(21):1697–1703.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2018;40(3):237–269.
   Google Scholar
• de Lemos JA, Drazner MH, Omland T, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA. 2010;304(22):2503–2512.
   PubMed Web of Science ®Google Scholar
• Zochios V, Valchanov K. Raised cardiac troponin in intensive care patients with sepsis, in the absence of angiographically documented coronary artery disease: A systematic review. J Intensive Care Soc. 2015;16(1):52–57.
   PubMedGoogle Scholar
• Imazio M, Klingel K, Kindermann I, et al. COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis? Heart. 2020;106(15):1127–1131.
   PubMed Web of Science ®Google Scholar
• Bradham WS, Bian A, Oeser A, et al. High-sensitivity cardiac troponin-I is elevated in patients with rheumatoid arthritis, independent of cardiovascular risk factors and inflammation. PLoS One. 2012;7(6):e38930.
   PubMed Web of Science ®Google Scholar
• Mariathas M, Olechowski B, Mahmoudi M, et al. High sensitivity troponins in contemporary cardiology practice: are we turning a corner? Expert Rev Cardiovasc Ther. 2018;16(1):49–57.
   PubMed Web of Science ®Google Scholar
• Mariathas M, Allan R, Ramamoorthy S, et al. True 99th centile of high sensitivity cardiac troponin for hospital patients: prospective, observational cohort study. BMJ. 2019;364:l729.
   PubMedGoogle Scholar
• Hinton J, Mariathas M, Grocott MP, et al. High Sensitivity troponin measurement in critical care: flattering to deceive or ‘never means nothing’? J Int Care So. 2019;21(3):232–240.
   Google Scholar
• Chapman AR, Bularga A, Mills NL. High-sensitivity cardiac troponin can be an ally in the fight against COVID-19. Circulation. 2020;141(22):1733–1735.
   PubMed Web of Science ®Google Scholar
• Doust JA, Glasziou PP, Pietrzak E, et al. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med. 2004;164(18):1978–1984.
   PubMedGoogle Scholar
• Boomsma F, van den Meiracker AH, Plasma A. and B-type natriuretic peptides: physiology, methodology and clinical use. Cardiovasc Res. 2001;51(3):442–449.
   PubMed Web of Science ®Google Scholar
• Wu AH. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results. Am Heart J. 2006;152(5):828–834.
   PubMed Web of Science ®Google Scholar
• Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002;40(5):976–982.
   PubMed Web of Science ®Google Scholar
• Madamanchi C, Alhosaini H, Sumida A, et al. Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure. Int J Cardiol. 2014;176(3):611–617.
   PubMed Web of Science ®Google Scholar
• Keller T, Zeller T, Peetz D, et al., Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med. 361(9): 868–877. 2009.
   PubMed Web of Science ®Google Scholar
• Aldous SJ, Florkowski CM, Crozier IG, et al. Comparison of high sensitivity and contemporary troponin assays for the early detection of acute myocardial infarction in the emergency department. Ann Clin Biochem. 2011;48(Pt 3):241–248.
   PubMedGoogle Scholar
• Rubini Gimenez M, Twerenbold R, Reichlin T, et al. Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction. Eur Heart J. 2014;35(34):2303–2311.
   PubMed Web of Science ®Google Scholar
• Reichlin T, Twerenbold R, Reiter M, et al. Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis. Am J Med. 2012;125(12):1205–13.e1.
   PubMed Web of Science ®Google Scholar
• Bandstein N, Wikman A, Ljung R, et al. Survival and resource utilization in patients with chest pain evaluated with cardiac troponin T compared with high-sensitivity cardiac troponin T. Int J Cardiol. 2017;245:43–48.
   PubMed Web of Science ®Google Scholar
• Corsini A, Vagnarelli F, Bugani G, et al. Impact of high-sensitivity Troponin T on hospital admission, resources utilization, and outcomes. Eur Heart J Acute Cardiovasc Care. 2015;4(2):148–157.
   PubMed Web of Science ®Google Scholar
• Yip TP, Pascoe HM, Lane SE. Impact of high-sensitivity cardiac troponin I assays on patients presenting to an emergency department with suspected acute coronary syndrome. Med J Aust. 2014;201(3):158–161.
   PubMed Web of Science ®Google Scholar
• Shah ASV, Anand A, Strachan FE, et al., High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial. Lancet. 392(10151): 919–928. 2018.
   PubMed Web of Science ®Google Scholar
• Chapman AR, Adamson PD, Shah ASV, et al. High-sensitivity cardiac troponin and the universal definition of myocardial infarction. Circulation. 2019;141:161–171.
   PubMedGoogle Scholar
• Rubini Gimenez M, Twerenbold R, Jaeger C, et al. One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am J Med. 2015;128(8):861–70.e4.
   PubMed Web of Science ®Google Scholar
• Reichlin T, Schindler C, Drexler B, et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med. 2012;172(16):1211–1218.
   PubMedGoogle Scholar
• Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the european society of cardiology (ESC). Eur Heart J. 2016;37(3):267–315.
   PubMed Web of Science ®Google Scholar
• Rubini Giménez M, Hoeller R, Reichlin T, et al. Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin. Int J Cardiol. 2013;168(4):3896–3901.
   PubMed Web of Science ®Google Scholar
• Hoeller R, Rubini Giménez M, Reichlin T, et al. Normal presenting levels of high-sensitivity troponin and myocardial infarction. Heart. 2013;99(21):1567–1572.
   PubMed Web of Science ®Google Scholar
• Casals G, Filella X, Bedini JL. Evaluation of a new ultrasensitive assay for cardiac troponin I. Clin Biochem. 2007;40(18):1406–1413.
   PubMed Web of Science ®Google Scholar
• Giannitsis E, Becker M, Kurz K, et al. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin Chem. 2010;56(4):642–650.
   PubMed Web of Science ®Google Scholar
• Apple FS, Pearce LA, Smith SW, et al. Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events. Clin Chem. 2009;55(5):930–937.
   PubMed Web of Science ®Google Scholar
• Casals G, Filella X, Augé JM, et al. Impact of ultrasensitive cardiac troponin I dynamic changes in the new universal definition of myocardial infarction. Am J Clin Pathol. 2008;130(6):964–968.
   PubMed Web of Science ®Google Scholar
• Neumann JT, Twerenbold R, Ojeda F, et al. Application of high-sensitivity troponin in suspected myocardial infarction. N Engl J Med. 2019;380(26):2529–2540.
   PubMed Web of Science ®Google Scholar
• Shah ASV, Sandoval Y, Noaman A, et al. Patient selection for high sensitivity cardiac troponin testing and diagnosis of myocardial infarction: prospective cohort study. BMJ. 2017;359:j4788.
   PubMed Web of Science ®Google Scholar
• Reiter M, Twerenbold R, Reichlin T, et al. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J. 2011;32(11):1379–1389.
   PubMed Web of Science ®Google Scholar
• Zhang SJ, Wang Q, Cui YJ, et al. High-sensitivity cardiac troponin T in geriatric inpatients. Arch Gerontol Geriatr. 2016;65:111–115.
   PubMed Web of Science ®Google Scholar
• Kaura A, Panoulas V, Glampson B, et al. Association of troponin level and age with mortality in 250 000 patients: cohort study across five UK acute care centres. BMJ. 2019;367:l6055.
   PubMedGoogle Scholar
• Nagarajan V, Hernandez AV, Tang WH. Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review. Heart. 2012;98(24):1778–1786.
   PubMed Web of Science ®Google Scholar
• Aimo A, Januzzi JL, Vergaro G, et al. Prognostic value of high-sensitivity troponin T in chronic heart failure: an individual patient data meta-analysis. Circulation. 2018;137(3):286–297.
   PubMed Web of Science ®Google Scholar
• Grodin JL, Neale S, Wu Y, et al. Prognostic comparison of different sensitivity cardiac troponin assays in stable heart failure. Am J Med. 2015;128(3):276–282.
   PubMed Web of Science ®Google Scholar
• Pang PS, Teerlink JR, Voors AA, et al. Use of high-sensitivity troponin T to identify patients with acute heart failure at lower risk for adverse outcomes: an exploratory analysis from the RELAX-AHF trial. JACC Heart Fail. 2016;4(7):591–599.
   PubMed Web of Science ®Google Scholar
• Kubo T, Kitaoka H, Yamanaka S, et al. Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2013;62(14):1252–1259.
   PubMed Web of Science ®Google Scholar
• Moreno V, Hernández-Romero D, Vilchez JA, et al. Serum levels of high-sensitivity troponin T: a novel marker for cardiac remodeling in hypertrophic cardiomyopathy. J Card Fail. 2010;16(12):950–956.
   PubMed Web of Science ®Google Scholar
• Kawahara C, Tsutamoto T, Nishiyama K, et al. Prognostic role of high-sensitivity cardiac troponin T in patients with nonischemic dilated cardiomyopathy. Circ J. 2011;75(3):656–661.
   PubMed Web of Science ®Google Scholar
• Takashio S, Yamamuro M, Izumiya Y, et al. Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis. ESC Heart Fail. 2018;5(1):27–35.
   PubMed Web of Science ®Google Scholar
• Dispenzieri A, Gertz MA, Kumar SK, et al. High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis. Heart. 2014;100(5):383–388.
   PubMed Web of Science ®Google Scholar
• McCarthy CP, Donnellan E, Phelan D, et al. High sensitivity troponin and valvular heart disease. Trends Cardiovasc Med. 2017;27(5):326–333.
   PubMed Web of Science ®Google Scholar
• Røsjø H, Andreassen J, Edvardsen T, et al. Prognostic usefulness of circulating high-sensitivity troponin T in aortic stenosis and relation to echocardiographic indexes of cardiac function and anatomy. Am J Cardiol. 2011;108(1):88–91.
   PubMed Web of Science ®Google Scholar
• Solberg OG, Ueland T, Wergeland R, et al. High-sensitive troponin T and N-terminal-brain-natriuretic-peptide predict outcome in symptomatic aortic stenosis. Scand Cardiovasc J. 2012;46(5):278–285.
   PubMed Web of Science ®Google Scholar
• Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–2791.
   PubMed Web of Science ®Google Scholar
• Chin CW, Shah AS, McAllister DA, et al. High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis. Eur Heart J. 2014;35(34):2312–2321.
   PubMed Web of Science ®Google Scholar
• Omland T, Pfeffer MA, Solomon SD, et al. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol. 2013;61(12):1240–1249.
   PubMed Web of Science ®Google Scholar
• Kavsak PA, Xu L, Yusuf S, et al. High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population. Clin Chem. 2011;57(8):1146–1153.
   PubMed Web of Science ®Google Scholar
• Everett BM, Brooks MM, Vlachos HE, et al. Troponin and cardiac events in stable ischemic heart disease and diabetes. N Engl J Med. 2015;373(7):610–620.
   PubMed Web of Science ®Google Scholar
• Korosoglou G, Lehrke S, Mueller D, et al. Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque. Heart. 2011;97(10):823–831.
   PubMed Web of Science ®Google Scholar
• Koenig W, Breitling LP, Hahmann H, et al. Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up. Clin Chem. 2012;58(8):1215–1224.
   PubMed Web of Science ®Google Scholar
• Biener M, Giannitsis E, Lamerz J, et al. Prognostic value of elevated high-sensitivity cardiac troponin T levels in a low risk outpatient population with cardiovascular disease. Eur Heart J Acute Cardiovasc Care. 2016;5(6):409–418.
   PubMed Web of Science ®Google Scholar
• Samman Tahhan A, Sandesara P, Hayek SS, et al. High-sensitivity troponin i levels and coronary artery disease severity, progression, and long-term outcomes. J Am Heart Assoc. 2018;7(5):5.
   Web of Science ®Google Scholar
• Cavender MA, White WB, Jarolim P, et al. Serial measurement of high-sensitivity troponin I and cardiovascular outcomes in patients with type 2 diabetes mellitus in the EXAMINE trial (examination of cardiovascular outcomes with alogliptin versus standard of care). Circulation. 2017;135(20):1911–1921.
   PubMed Web of Science ®Google Scholar
• Bonaca MP, O’Malley RG, Jarolim P, et al. Serial cardiac troponin measured using a high-sensitivity assay in stable patients with ischemic heart disease. J Am Coll Cardiol. 2016;68(3):322–323.
   PubMed Web of Science ®Google Scholar
• Lipid modification - CVD prevention: National institute for health and care excellence; 2019 [cited 2020 Jun 10]. Available from: https://cks.nice.org.uk/lipid-modification-cvd-prevention#!scenario:1.
   Google Scholar
• Adamson PD, McAllister D, Pilbrow A, et al. Convalescent troponin and cardiovascular death following acute coronary syndrome. Heart. 2019;105(22):1717–1724.
   PubMed Web of Science ®Google Scholar
• Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165.
   PubMed Web of Science ®Google Scholar
• Ndrepepa G, Braun S, Cassese S, et al. Prognostic value of high-sensitivity troponin T after percutaneous coronary intervention in patients with stable coronary artery disease. Rev Esp Cardiol (Engl Ed). 2016;69(8):746–753.
   PubMed Web of Science ®Google Scholar
• Ndrepepa G, Colleran R, Braun S, et al. High-sensitivity troponin T and mortality after elective percutaneous coronary intervention. J Am Coll Cardiol. 2016;68(21):2259–2268.
   PubMed Web of Science ®Google Scholar
• Vieira de Melo RM, Hueb W, Nomura CH, et al. Biomarker release after percutaneous coronary intervention in patients without established myocardial infarction as assessed by cardiac magnetic resonance with late gadolinium enhancement. Catheter Cardiovasc Interv. 2017;90(1):87–93.
   PubMed Web of Science ®Google Scholar
• Zeitouni M, Silvain J, Guedeney P, et al. Periprocedural myocardial infarction and injury in elective coronary stenting. Eur Heart J. 2018;39(13):1100–1109.
   PubMed Web of Science ®Google Scholar
• Wang TK, Stewart RA, Ramanathan T, et al. Diagnosis of MI after CABG with high-sensitivity troponin T and new ECG or echocardiogram changes: relationship with mortality and validation of the universal definition of MI. Eur Heart J Acute Cardiovasc Care. 2013;2(4):323–333.
   PubMedGoogle Scholar
• Brynildsen J, Petäjä L, Pettilä V, et al. The predictive value of NT-proBNP and hs-TnT for risk of death in cardiac surgical patients. Clin Biochem. 2018;53:65–71.
   PubMed Web of Science ®Google Scholar
• Anegawa T, Kai H, Adachi H, et al. High-sensitive troponin T is associated with atrial fibrillation in a general population. Int J Cardiol. 2012;156(1):98–100.
   PubMed Web of Science ®Google Scholar
• Hijazi Z, Wallentin L, Siegbahn A, et al. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin. J Am Coll Cardiol. 2014;63(1):52–61.
   PubMed Web of Science ®Google Scholar
• Hijazi Z, Oldgren J, Andersson U, et al. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy. Circulation. 2012;125(13):1605–1616.
   PubMed Web of Science ®Google Scholar
• Mariathas M, Gemmell C, Olechowski B, et al. High sensitivity troponin in the management of tachyarrhythmias. Cardiovasc Revasc Med. 2017;19(5 Pt A):487–492.
   PubMed Web of Science ®Google Scholar
• Costabel JP, Urdapilleta M, Lambardi F, et al. High-sensitivity cardiac troponin levels in supraventricular tachyarrhythmias. Pacing Clin Electrophysiol. 2016;39(6):588–591.
   PubMed Web of Science ®Google Scholar
• Bajaj A, Rathor P, Sehgal V, et al. Prognostic value of biomarkers in acute non-massive pulmonary embolism: a systematic review and meta-analysis. Lung. 2015;193(5):639–651.
   PubMed Web of Science ®Google Scholar
• Lankeit M, Friesen D, Aschoff J, et al. Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism. Eur Heart J. 2010;31(15):1836–1844.
   PubMed Web of Science ®Google Scholar
• Lankeit M, Jiménez D, Kostrubiec M, et al. Predictive value of the high-sensitivity troponin T assay and the simplified pulmonary embolism severity index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study. Circulation. 2011;124(24):2716–2724.
   PubMed Web of Science ®Google Scholar
• Sin DD, Anthonisen NR, Soriano JB, et al. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245–1257.
   PubMed Web of Science ®Google Scholar
• Høiseth AD, Neukamm A, Hagve TA, et al. The clinical value of serial measurement of high-sensitivity cardiac troponin T in acute exacerbations of chronic obstructive pulmonary disease. Open Heart. 2014;1(1):e000001.
   PubMedGoogle Scholar
• Høiseth AD, Neukamm A, Karlsson BD, et al. Elevated high-sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary disease. Thorax. 2011;66(9):775–781.
   PubMed Web of Science ®Google Scholar
• Neukamm A, Einvik G, Didrik Høiseth A, et al. The prognostic value of measurement of high-sensitive cardiac troponin T for mortality in a cohort of stable chronic obstructive pulmonary disease patients. BMC Pulm Med. 2016;16(1):164.
   PubMedGoogle Scholar
• Prosser J, MacGregor L, Lees KR, et al. Predictors of early cardiac morbidity and mortality after ischemic stroke. Stroke. 2007;38(8):2295–2302.
   PubMed Web of Science ®Google Scholar
• Faiz KW, Thommessen B, Einvik G, et al. Determinants of high sensitivity cardiac troponin T elevation in acute ischemic stroke. BMC Neurol. 2014;14:96.
   PubMed Web of Science ®Google Scholar
• Faiz KW, Thommessen B, Einvik G, et al. Prognostic value of high-sensitivity cardiac troponin T in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23(2):241–248.
   PubMed Web of Science ®Google Scholar
• Kumar N, Michelis MF, DeVita MV, et al. Troponin I levels in asymptomatic patients on haemodialysis using a high-sensitivity assay. Nephrol Dial Transplant. 2011;26(2):665–670.
   PubMed Web of Science ®Google Scholar
• Pianta TJ, Horvath AR, Ellis VM, et al. Cardiac high-sensitivity troponin T measurement: a layer of complexity in managing haemodialysis patients. Nephrology (Carlton). 2012;17(7):636–641.
   PubMed Web of Science ®Google Scholar
• Iliou MC, Fumeron C, Benoit MO, et al. Prognostic value of cardiac markers in ESRD: chronic hemodialysis and new cardiac markers evaluation (CHANCE) study. Am J Kidney Dis. 2003;42(3):513–523.
   PubMed Web of Science ®Google Scholar
• Gunsolus I, Sandoval Y, Smith SW, et al. Renal dysfunction influences the diagnostic and prognostic performance of high-sensitivity cardiac troponin I. J Am Soc Nephrol. 2018;29(2):636–643.
   PubMed Web of Science ®Google Scholar
• Miller-Hodges E, Anand A, Shah ASV, et al. High-sensitivity cardiac troponin and the risk stratification of patients with renal impairment presenting with suspected acute coronary syndrome. Circulation. 2018;137(5):425–435.
   PubMed Web of Science ®Google Scholar
• Bansal N, Hyre Anderson A, Yang W, et al. High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the chronic renal insufficiency cohort (CRIC) Study. J Am Soc Nephrol. 2015;26(4):946–956.
   PubMed Web of Science ®Google Scholar
• Bansal N, Katz R, Dalrymple L, et al. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults. Clin J Am Soc Nephrol. 2015;10(2):205–214.
   PubMed Web of Science ®Google Scholar
• Scheven L, de Jong PE, Hillege HL, et al. High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate. Eur Heart J. 2012;33(18):2272–2281.
   PubMed Web of Science ®Google Scholar
• Zardavas D, Suter TM, Van Veldhuisen DJ, et al. Role of troponins I and T and N-terminal prohormone of brain natriuretic peptide in monitoring cardiac safety of patients with early-stage human epidermal growth factor receptor 2-positive breast cancer receiving trastuzumab: a herceptin adjuvant study cardiac marker substudy. J Clin Oncol. 2017;35(8):878–884.
   PubMed Web of Science ®Google Scholar
• Sawaya H, Sebag IA, Plana JC, et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol. 2011;107(9):1375–1380.
   PubMed Web of Science ®Google Scholar
• Ky B, Putt M, Sawaya H, et al. Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab. J Am Coll Cardiol. 2014;63(8):809–816.
   PubMed Web of Science ®Google Scholar
• Michel L, Mincu RI, Mahabadi AA, et al. Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta-analysis. Eur J Heart Fail. 2020;22(2):350–361.
   PubMed Web of Science ®Google Scholar
• Blankenberg S, Salomaa V, Makarova N, et al. Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium. Eur Heart J. 2016;37(30):2428–2437.
   PubMed Web of Science ®Google Scholar
• Evans JDW, Dobbin SJH, Pettit SJ, et al. High-sensitivity cardiac troponin and new-onset heart failure: a systematic review and meta-analysis of 67,063 patients with 4,165 incident heart failure events. JACC Heart Fail. 2018;6(3):187–197.
   PubMed Web of Science ®Google Scholar
• Everett BM, Zeller T, Glynn RJ, et al. High-sensitivity cardiac troponin I and B-type natriuretic Peptide as predictors of vascular events in primary prevention: impact of statin therapy. Circulation. 2015;131(21):1851–1860.
   PubMed Web of Science ®Google Scholar
• Ford I, Shah AS, Zhang R, et al. High-sensitivity cardiac troponin, statin therapy, and risk of coronary heart disease. J Am Coll Cardiol. 2016;68(25):2719–2728.
   PubMed Web of Science ®Google Scholar
• Jia X, Sun W, Hoogeveen RC, et al. High-sensitivity troponin I and incident coronary events, stroke, heart failure hospitalization, and mortality in the ARIC study. Circulation. 2019;139(23):2642–2653.
   PubMed Web of Science ®Google Scholar
• Lyngbakken MN, Røsjø H, Holmen OL, et al. Temporal changes in cardiac troponin I are associated with risk of cardiovascular events in the general population: the nord-trøndelag health study. Clin Chem. 2019;65(7):871–881.
   PubMed Web of Science ®Google Scholar
• Neumann JT, Havulinna AS, Zeller T, et al. Comparison of three troponins as predictors of future cardiovascular events–prospective results from the FINRISK and BiomaCaRE studies. PLoS One. 2014;9(3):e90063.
   PubMed Web of Science ®Google Scholar
• Than MP, Aldous SJ, Troughton RW, et al. Detectable high-sensitivity cardiac troponin within the population reference interval conveys high 5-year cardiovascular risk: an observational study. Clin Chem. 2018;64(7):1044–1053.
   PubMed Web of Science ®Google Scholar
• van der Linden N, Klinkenberg LJ, Bekers O, et al. Prognostic value of basal high-sensitive cardiac troponin levels on mortality in the general population: A meta-analysis. Medicine (Baltimore). 2016;95(52):e5703.
   PubMed Web of Science ®Google Scholar
• Wang TJ, Wollert KC, Larson MG, et al. Prognostic utility of novel biomarkers of cardiovascular stress: the framingham heart study. Circulation. 2012;126(13):1596–1604.
   PubMed Web of Science ®Google Scholar
• Willeit P, Welsh P, Evans JDW, et al. High-sensitivity cardiac troponin concentration and risk of first-ever cardiovascular outcomes in 154,052 participants. J Am Coll Cardiol. 2017;70(5):558–568.
   PubMed Web of Science ®Google Scholar
• Xiao W, Cao R, Liu Y, et al. Association of high-sensitivity cardiac troponin T with mortality and cardiovascular events in a community-based prospective study in Beijing. BMJ Open. 2017;7(6):e013431.
   PubMed Web of Science ®Google Scholar
• Welsh P, Preiss D, Hayward C, et al. Cardiac troponin T and Troponin I in the general population. Circulation. 2019;139(24):2754–2764.
   PubMed Web of Science ®Google Scholar
• Zhu K, Knuiman M, Divitini M, et al. High-sensitivity cardiac troponin I and risk of cardiovascular disease in an Australian population-based cohort. Heart. 2018;104(11):895–903.
   PubMed Web of Science ®Google Scholar
• Mariathas M, Curzen N. Troponin assays: entering a brave new world? Lancet. 2018 Jun 16;391(10138):2398–2399. DOI:10.1016/S0140-6736(17)32342-5.
   Google Scholar
• Everett BM. Cardiac troponin: the next tool for cardiovascular disease prevention in ambulatory patients? Heart. 2018;104(11):875–877.
   PubMed Web of Science ®Google Scholar
• Leckie T, Richardson A, Watkins E, et al. High-sensitivity troponin T in marathon runners, marathon runners with heart disease and collapsed marathon runners. Scand J Med Sci Sports. 2019;29(5):663–668.
   PubMed Web of Science ®Google Scholar
• Legaz-Arrese A, Carranza-García LE, Navarro-Orocio R, et al. Cardiac biomarker release after endurance exercise in male and female adults and adolescents. J Pediatr. 2017;191:96–102.
   PubMed Web of Science ®Google Scholar
• Tian Y, Nie J, Huang C, et al. The kinetics of highly sensitive cardiac troponin T release after prolonged treadmill exercise in adolescent and adult athletes. J Appl Physiol (1985). 2012;113(3):418–425.
   PubMed Web of Science ®Google Scholar
• Aengevaeren VL, Hopman MTE, Thompson PD, et al. Exercise-induced cardiac troponin i increase and incident mortality and cardiovascular events. Circulation. 2019;140(10):804–814.
   PubMed Web of Science ®Google Scholar
• Scherr J, Braun S, Schuster T, et al. 72-h kinetics of high-sensitive troponin T and inflammatory markers after marathon. Med Sci Sports Exerc. 2011;43(10):1819–1827.
   PubMed Web of Science ®Google Scholar
• Baron JM, Lewandrowski EL, Januzzi JL, et al. Measurement of high-sensitivity troponin T in noncardiac medical intensive care unit patients. Correlation to mortality and length of stay. Am J Clin Pathol. 2014;141(4):488–493.
   PubMed Web of Science ®Google Scholar
• Crewdson K, Thompson J, Thomas M. Cardiac troponin T is associated with mortality in patients admitted to critical care in a UK major trauma centre: a retrospective database analysis. J Intensive Care Soc. 2019;20(2):132–137.
   PubMedGoogle Scholar
• Røsjø H, Varpula M, Hagve TA, et al. Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome. Intensive Care Med. 2011;37(1):77–85.
   PubMed Web of Science ®Google Scholar
• Landesberg G, Jaffe AS, Gilon D, et al. Troponin elevation in severe sepsis and septic shock: the role of left ventricular diastolic dysfunction and right ventricular dilatation*. Crit Care Med. 2014;42(4):790–800.
   PubMed Web of Science ®Google Scholar
• Frencken JF, Donker DW, Spitoni C, et al. Myocardial injury in patients with sepsis and its association with long-term outcome. Circ Cardiovasc Qual Outcomes. 2018;11(2):e004040.
   PubMed Web of Science ®Google Scholar
• Devereaux PJ, Biccard BM, Sigamani A, et al. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2017;317(16):1642–1651.
   PubMed Web of Science ®Google Scholar
• Brown JC, Samaha E, Rao S, et al. High-sensitivity cardiac troponin t improves the diagnosis of perioperative MI. Anesth Analg. 2017;125(5):1455–1462.
   PubMed Web of Science ®Google Scholar
• Noordzij PG, van Geffen O, Dijkstra IM, et al. High-sensitive cardiac troponin T measurements in prediction of non-cardiac complications after major abdominal surgery. Br J Anaesth. 2015;114(6):909–918.
   PubMed Web of Science ®Google Scholar
• Ackland GL, Abbott TEF, Jones TF, et al. Early elevation in plasma high-sensitivity troponin T and morbidity after elective noncardiac surgery: prospective multicentre observational cohort study. Br J Anaesth. 2020;124(5):535–543.
   PubMed Web of Science ®Google Scholar
• Devereaux PJ, Duceppe E, Guyatt G, et al. Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial. Lancet. 2018;391(10137):2325–2334.
   PubMed Web of Science ®Google Scholar
• Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139–1151.
   PubMed Web of Science ®Google Scholar
• Atri D, Siddiqi HK, Lang J, et al. COVID-19 for the cardiologist: a current review of the virology, clinical epidemiology, cardiac and other clinical manifestations and potential therapeutic strategies. JACC Basic Transl Sci. 2020;5(5):518–536.
   PubMedGoogle Scholar
• Huang R, Xia J, Chen Y, et al. A family cluster of SARS-CoV-2 infection involving 11 patients in Nanjing, China. Lancet Infect Dis. 2020;20(5):534–535.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):802–810.
   PubMed Web of Science ®Google Scholar
• Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802–810.
   PubMed Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069.
   PubMed Web of Science ®Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323(20):2052–2059.
   PubMed Web of Science ®Google Scholar
• Li X, Pan X, Li Y, et al. Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review. Crit Care. 2020;24(1):468.
   PubMed Web of Science ®Google Scholar
• Januzzi J. Troponin and BNP Use in COVID-19: american College of Cardiology; 2020 [cited 2020 Sep 1]. Available from: https://www.acc.org/latest-in-cardiology/articles/2020/03/18/15/25/troponin-and-bnp-use-in-covid19.
   Google Scholar